For much of this US bull market, the usual soundtrack of rising stocks has been missing. In prior expansions—especially those powered by broad optimism and improving liquidity—equity markets tend to attract a familiar flow of new supply: follow-on offerings, secondary sales by insiders, IPOs that arrive once valuations look “safe,” and a steady stream of capital raises that reflect both corporate confidence and investor appetite. This time, the rally has advanced without the same deluge of issuance. The result is not just a technical curiosity for market microstructure nerds; it changes how risk is priced, how investors position, and how resilient the market feels when sentiment wobbles.
At the center of the debate is what some investors have come to think of as a “de-equitisation put.” The phrase is shorthand for a pattern: when equity markets run hot, companies often respond by selling shares into strength, which can cap upside in the short term. But when issuance is unusually light, the market can behave as if there is an implicit backstop—less new stock hitting the tape means fewer forced sellers, less dilution risk, and a thinner pipeline of supply that might otherwise weigh on valuations. In other words, the absence of issuance can act like a cushion. It doesn’t guarantee returns, but it can reduce the frequency and severity of drawdowns driven by supply shocks.
Now, the question being asked across trading desks and capital markets teams is whether the AI boom could end that cushion.
The mechanics are straightforward, even if the implications are not. Equity issuance is not merely a reflection of corporate strategy; it is also a barometer of timing. When markets are strong, management teams and bankers typically find it easier to justify raising capital at higher prices. Investors, too, become more willing to underwrite deals when momentum is positive. That’s why many bull markets eventually generate their own counterweight: as valuations rise, the cost of issuing equity falls relative to the benefit of funding growth, refinancing balance sheets, or buying assets. The market becomes a place where capital can be mobilized quickly.
But in this cycle, the mobilization hasn’t matched the pace of the rally. That mismatch has mattered. When equity issuance is subdued, the market can absorb inflows more easily. Price discovery becomes cleaner because fewer large transactions compete for attention. Liquidity can improve without the same degree of dilution overhang. And perhaps most importantly for investors who care about downside protection, the market may be less vulnerable to sudden repricing events tied to supply.
This is where AI enters the story—not as a vague theme, but as a potential catalyst for a shift in corporate behavior.
AI is already reshaping capital needs. The buildout of compute infrastructure, data pipelines, specialized chips, energy capacity, and the talent required to deploy models at scale is expensive and often front-loaded. Even when revenue growth is strong, the path from investment to monetization can be uneven. That creates a structural incentive to secure funding early, before the market turns or before internal cash generation catches up. In past technology cycles, that dynamic often translated into more equity issuance once the market’s confidence was high enough to support it.
So far, the AI-driven expansion appears to have delivered a powerful equity bid without triggering the same issuance response. That could be because companies have had alternative funding routes—cash flow, debt markets, vendor financing, strategic partnerships, or internal capital allocation. It could also reflect the fact that some AI beneficiaries are concentrated in a smaller set of mega-cap names that can fund themselves more easily than the broader market. Another possibility is that investors have been willing to treat AI-related capex as “growth investment” rather than a reason to dilute shareholders immediately, especially when margins and demand signals look promising.
Yet the longer the rally continues, the more difficult it becomes for the market to remain in a low-issuance equilibrium. Capital markets are not static. They respond to both opportunity and necessity. If AI spending accelerates further, if deal activity increases, or if valuations become high enough that management teams see issuance as a rational trade-off, the pipeline of equity supply could start to widen.
That widening is what would threaten the de-equitisation put.
To understand why, it helps to think about what investors have been implicitly relying on. When issuance is low, the market’s upward momentum can be sustained by a relatively simple equation: demand for equities rises, supply does not rise proportionally, and the marginal buyer can keep paying higher prices without immediately confronting dilution risk. In such an environment, the market can look “sticky.” Even when macro news is mixed, the absence of new share supply can limit the magnitude of selloffs.
But if AI-related funding needs begin to translate into more IPOs, follow-ons, and secondary offerings, the equation changes. New supply doesn’t just add shares; it adds uncertainty. Investors must reassess whether the rally is being supported by fundamentals or by a temporary imbalance between buyers and sellers. They also need to price the possibility that future earnings growth will be diluted by capital raises, or that the market is entering a phase where companies are taking advantage of high valuations to fund expansion.
In practice, the first sign of this shift is rarely a single dramatic event. It is usually a gradual change in the cadence of deals. A few follow-on offerings can be absorbed. A handful of IPOs can be digested. But when the pattern becomes consistent—when issuance ramps alongside equity momentum—the market starts to anticipate supply rather than ignore it. That anticipation can compress valuation multiples even if earnings expectations remain intact, because investors begin to demand a higher risk premium for holding equities through periods of dilution.
There is also a second-order effect: issuance can influence volatility and positioning. When investors believe the market is protected by low supply, they may take less hedging cost, reduce downside exposure, or allocate more aggressively to equities. If issuance then rises, the market can experience a sharper repricing because portfolios were built for a different regime. In other words, the threat is not only that new shares are sold—it’s that the market’s risk pricing model may be wrong.
AI could accelerate this regime shift in several ways.
First, AI is not one industry; it is a network of industries. The winners include software platforms, cloud providers, semiconductor manufacturers, data infrastructure firms, cybersecurity vendors, and a growing ecosystem of companies building tools for model training, deployment, and governance. Many of these businesses are still scaling. Scaling often requires capital. Even if some players can fund growth internally, others will need external financing to expand capacity, acquire customers, or invest in R&D at the pace demanded by competition.
Second, AI is driving a wave of strategic transactions. Mergers and acquisitions, partnerships that involve equity components, and asset purchases can all lead to equity issuance indirectly. When companies use stock as currency—whether to acquire capabilities, consolidate supply chains, or buy distribution—equity supply can increase even without a headline IPO boom. That means the market could see more “hidden issuance” through deal structures, not just through traditional capital raises.
Third, AI is changing the investor base. Some investors treat AI exposure as a long-duration theme and are willing to hold through volatility. Others are more tactical, rotating into and out of AI-linked names based on near-term catalysts. If issuance rises, tactical investors may become more sensitive to dilution and deal terms, while long-duration investors may demand clearer evidence of monetization. Either way, the market’s tolerance for uncertainty can shrink.
Fourth, the AI cycle may create a timing mismatch between capex and cash generation. In earlier tech booms, companies often raised equity to fund growth and then gradually converted that growth into earnings. But the AI buildout can be more capital-intensive upfront, and the monetization curve can be lumpy. When cash conversion lags, management teams may prefer to raise equity rather than rely solely on debt—especially if interest rates are volatile or if credit conditions tighten. That preference can show up as more issuance once the market is strong enough to support it.
None of this guarantees that issuance will surge immediately. Markets can stay in a low-supply state longer than expected, particularly if companies believe they can finance growth through other channels. But the risk is that the market’s current resilience is partly a function of supply restraint, and supply restraint is not a permanent feature of any bull market.
There is also a subtle behavioral element. When equity issuance is scarce, it can become a kind of “scarcity premium.” Investors may pay more for shares because they know fewer new shares will dilute them. Companies, meanwhile, may delay issuance because the market is rewarding existing holders and because management teams often prefer to avoid diluting shareholders unless necessary. But as AI spending requirements become more urgent, the delay can end. Once the threshold is crossed—when internal funding is no longer sufficient or when competitive pressure forces faster scaling—companies may decide that the cost of waiting is higher than the cost of issuing.
That is why the next phase matters: not just whether issuance rises, but whether it rises in a way that is synchronized with market momentum. If issuance increases during a period of strong equity performance, it can be interpreted as opportunistic. Investors may accept it more readily than if issuance spikes during a downturn. Yet even in that “good timing” scenario, the market can still face a valuation reset because the supply overhang becomes part of the forward-looking narrative.
What should investors watch?
The first thing is the obvious: the number and size of IPOs, follow-on offerings, and secondary share sales. But the more informative signal is the trend in issuance relative to market performance. A single deal can be dismissed as idiosyncratic. A sustained increase in issuance cadence is harder to ignore.
Second, watch the composition of issuance. If the deals are concentrated in a narrow set of AI beneficiaries, the impact may be localized at first. But if issuance broadens—if mid-cap and growth companies begin to tap equity markets more frequently—that suggests the market is moving from a “selective funding” regime to a “generalized funding” regime. That broader shift